Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

Solante, RontgeneRontgeneSolanteAlvarez-Moreno, CarlosCarlosAlvarez-MorenoBurhan, ErlinaErlinaBurhanChariyalertsak, SuwatSuwatChariyalertsakChiu, Nan-ChangNan-ChangChiuChuenkitmongkol, SunateSunateChuenkitmongkolDo-Van, DungDungDo-VanHwang, Kao-PinKao-PinHwangKiertiburanakul, SasisopinSasisopinKiertiburanakulPING-ING LEELobo, Rommel CrisenioRommel CrisenioLoboMacias, AlejandroAlejandroMaciasNghia, Cao HuuCao HuuNghiaOng-Lim, AnnaAnnaOng-LimOrtiz Ibarra, JavierJavierOrtiz IbarraRichtmann, RosanaRosanaRichtmannRodriguez-Morales, Alfonso JAlfonso JRodriguez-MoralesSafadi, Marco Aurélio PMarco Aurélio PSafadiSatari, Hindra IrawanHindra IrawanSatari2023-01-182023-01-182022-091476-0584https://scholars.lib.ntu.edu.tw/handle/123456789/627427en4th dose; AZD1222; BNT162b2; COVID-19; Southeast Asia; Thailand; booster; vaccine effectiveness[SDGs]SDG2[SDGs]SDG3Further implications on the global real-world vaccine effectiveness against SARS-CoV-2letter10.1080/14760584.2022.2110073359686712-s2.0-85136224339WOS:000842211200001https://api.elsevier.com/content/abstract/scopus_id/85136224339